Infection in Organ Transplantation
By J. Fishman. American Journal of Transplantation, 2017
715 citations recorded by the source corpus.
The prevention, diagnosis, and management of infectious disease in transplantation are major contributors to improved outcomes in organ transplantation. The risk of serious infections in organ recipients is determined by interactions between the patient's epidemiological exposures and net state of immune suppression. In organ recipients, there is a significant incidence of drug toxicity and a propensity for drug interactions with immunosuppressive agents used to maintain graft function. Thus, every effort must be made to establish specific microbiologic diagnoses to optimize therapy. A timeline can be created to develop a differential diagnosis of infection in transplantation based on common patterns of infectious exposures, immunosuppressive management, and antimicrobial prophylaxis. Application of quantitative molecular microbial assays and advanced antimicrobial therapies have advanced care. Pathogen‐specific immunity, genetic polymorphisms in immune responses, and dynamic interactions between the microbiome and the risk of infection are beginning to be explored. The role of infection in the stimulation of alloimmune responses awaits further definition. Major hurdles include the shifting worldwide epidemiology of infections, increasing antimicrobial resistance, suboptimal assays for the microbiologic screening of organ donors, and virus‐associated malignancies. Transplant infectious disease remains a key to the clinical and scientific investigation of organ transplantation.
View Paper: https://www.semanticscholar.org/paper/9c62de81e560474e6d276ed4460dd95f8914b817
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Satlin
- Marcus R. Pereira
- G. Dube
- Robert S. Brown
- Luke J. Benvenuto
- Sandip Kapur
- Lloyd E. Ratner
- David J. Cohen
Citations in the corpus
- COVID-19 in solid organ transplant recipients: Initial report from the US epicenter (2020, background): “001 Days from positive SARS-CoV-2 test until death or last follow-up, median (IQR) 20 (14-24) 20 (15-26) 15 (9-23) .”